Additional information
| Active substance | Memantine |
|---|---|
| Classification | NMDA Receptor Antagonists |
| Water Retention | No significant impact |
| Hepatotoxicity | Low risk |
| Lab Test | Not standard in sports or routine medical testing |
| Also known as | Axura, Ebixa, Memox, Adaxor |
| WAREHOUSE | International Warehouse 1 |
| Blood pressure | Can cause slight increase in blood pressure |
| Trade name | Namenda |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 1-amino-3,5-dimethyladamantane |
| Formula | C12H21N |
| Substance class | NMDA receptor antagonist |
| Main action | Reduces abnormal activity in the brain |
| Half-life | 60-100 hours |
| Dosage (medical) | Usually starts at 5 mg once daily, increasing to 10 mg twice daily as tolerated |
| Dosage (sports) | Not recommended for sports enhancement |
| Effects | Improves memory, awareness, and the ability to perform daily activities |
| Side effects | Dizziness, headache, confusion, hypertension |
| Use in sports | None |
| Manufacturer | Sun Pharma |
|
Reviews
There are no reviews yet.